102
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Lifting the Mask on Musculoskeletal Manifestations of COVID-19: Results of an Interview-Based Study

ORCID Icon, & ORCID Icon
Pages 211-220 | Received 30 May 2022, Accepted 19 Sep 2022, Published online: 04 Oct 2022

References

  • Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. 2021;268:3059–3071. doi:10.1007/s00415-021-10406-y
  • Hui DS, Azhar EI, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. doi:10.1016/j.ijid.2020.01.009
  • Zhao H, Shen D, Zhou H, Liu J, Chen SJ. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19:383–384. doi:10.1016/S1474-4422(20)30109-5
  • Madjid M, Safavi-Naeini P, Solomon SD, Vardeny OJ. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5:831–840. doi:10.1001/jamacardio.2020.1286
  • Gross O, Moerer O, Weber M, Huber TB, Scheithauer SJ. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020;395:e87–e8. doi:10.1016/S0140-6736(20)31041-2
  • Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest. 2021;159:1182–1196. doi:10.1016/j.chest.2020.11.005
  • Favas T, Dev P, Chaurasia RN, et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020;41:3437–3470. doi:10.1007/s10072-020-04801-y
  • Yamakawa M, Kuno T, Mikami T, et al. Clinical characteristics of stroke with COVID-19: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2020;29:105288. doi:10.1016/j.jstrokecerebrovasdis.2020.105288
  • Galeotti C, Bayry JJ. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16:413–414. doi:10.1038/s41584-020-0448-7
  • Disser NP, De Micheli AJ, Schonk MM, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102:1197. doi:10.2106/JBJS.20.00847
  • Abdullahi A, Candan SA, Abba MA, et al. Neurological and musculoskeletal features of COVID-19: a systematic review and meta-analysis. Front Neurol. 2020;11:687. doi:10.3389/fneur.2020.00687
  • Misra DP, Agarwal V, Gasparyan AY, Zimba OJ. Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol. 2020;39:2055–2062. doi:10.1007/s10067-020-05073-9
  • Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, Halil MJ. Sarcopenia in critically ill patients. J Anesth. 2016;30:884–890. doi:10.1007/s00540-016-2211-4
  • Kuorinka I, Jonsson B, Kilbom A, et al. Standardised Nordic questionnaires for the analysis of musculoskeletal symptoms. Appl Ergon. 1987;18:233–237. doi:10.1016/0003-6870(87)90010-X
  • Marks M, Marks JL. Viral arthritis. Clin Med. 2016;16:129. doi:10.7861/clinmedicine.16-2-129
  • Hoong CWS, Amin MN, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. Int J Infect Dis. 2021;104:363–369. doi:10.1016/j.ijid.2021.01.031
  • Shanbehzadeh S, Tavahomi M, Zanjari N, Ebrahimi-Takamjani I, Amiri-Arimi SJ. Physical and mental health complications post-COVID-19: scoping review. J Psychosom Res. 2021;147:110525. doi:10.1016/j.jpsychores.2021.110525
  • Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020;382:2372–2374. doi:10.1056/NEJMc2010419
  • Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, et al. Clinical features of the first cases and a cluster of Coronavirus Disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Travel Med Infect Dis. 2020;35:101653. doi:10.1016/j.tmaid.2020.101653
  • Kucuk A, Cumhur Cure M, Cure EJ. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol. 2020;39:2103–2104. doi:10.1007/s10067-020-05178-1
  • Batur EB, Korez MK, Gezer IA, Levendoglu F, Ural OJ. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID‐19. Int J Clin Pract. 2021;75:e14135. doi:10.1111/ijcp.14135
  • Ramani SL, Samet J, Franz CK, et al. Musculoskeletal involvement of COVID-19: review of imaging. Skeletal Radiol. 2021;50:1763–1773. doi:10.1007/s00256-021-03734-7
  • Mahase E. Covid-19: sore throat, fatigue, and myalgia are more common with new UK variant. BMJ. 2021;372:n288.
  • Lippi G, Wong J, Henry BM. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World J Emerg Med. 2020;11:193. doi:10.5847/wjem.j.1920-8642.2020.03.013
  • Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Fuensalida-Novo S, et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study. Pain. 2021;162:2832–2840. doi:10.1097/j.pain.0000000000002306
  • Huang Y, Tu M, Wang S, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis. Travel Med Infect Dis. 2020;36:101606. doi:10.1016/j.tmaid.2020.101606
  • Guan W-J, Ni Z-Y, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. NEJM. 2020;382:1708–1720. doi:10.1056/NEJMoa2002032
  • Friedman N, Alter H, Hindiyeh M, Mendelson E, Shemer Avni Y, Mandelboim MJV. Human coronavirus infections in Israel: epidemiology, clinical symptoms and summer seasonality of HCoV-HKU1. Viruses. 2018;10:515. doi:10.3390/v10100515
  • Memish ZA, Perlman S, Van Kerkhove MD, Zumla AJ. Middle East respiratory syndrome. Lancet. 2020;395:1063–1077. doi:10.1016/S0140-6736(19)33221-0
  • Varache S, Narbonne V, Jousse‐Joulin S, et al. Is routine viral screening useful in patients with recent‐onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study. Arthritis Care Res. 2011;63:1565–1570. doi:10.1002/acr.20576
  • Joob B, Wiwanitkit VJ. Arthralgia as an initial presentation of COVID-19: observation. Rheumatol Int. 2020;40:823. doi:10.1007/s00296-020-04561-0
  • Parisi S, Borrelli R, Bianchi S, Fusaro EJ. Viral arthritis and COVID-19. Lancet Rheumatol. 2020;2:e655–e7. doi:10.1016/S2665-9913(20)30348-9
  • Peral-Garrido ML, Calabuig I, Tovar-Sugrañes E, et al. Case series of acute arthritis during COVID-19 admission. Ann Rheum Dis. 2021;80:e58–e. doi:10.1136/annrheumdis-2020-217914
  • Fujinami RS, von Herrath MG, Christen U, Whitton JL. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev. 2006;19:80–94. doi:10.1128/CMR.19.1.80-94.2006
  • Cappello FJ. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? Clin Microbiol Rev. 2020;25:381–382.
  • Cappello F, Marino Gammazza A, Dieli F, Conway de Macario E, Macario AJ. Does SARS-CoV-2 trigger stress-induced autoimmunity by molecular mimicry? A hypothesis. J Clin Med. 2020;9:2038. doi:10.3390/jcm9072038
  • Angileri F, Legare S, Gammazza AM, de Macario EC, Macario AJ, Cappello FJ. Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev. 2020;19:102591. doi:10.1016/j.autrev.2020.102591
  • Cabello‐Verrugio C, Morales MG, Rivera JC, Cabrera D, Simon FJ. Renin‐angiotensin system: an old player with novel functions in skeletal muscle. Med Res Rev. 2015;35:437–463. doi:10.1002/med.21343
  • Ding Y, He L, Zhang Q, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203:622–630. doi:10.1002/path.1560
  • Kim T-H, Uhm W-S, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005;17:400–405. doi:10.1097/01.bor.0000163447.44037.c4
  • Yokogawa N, Minematsu N, Katano H, Suzuki TJ. Case of acute arthritis following SARS-CoV-2 infection. Ann Rheum Dis. 2021;80:e101–e. doi:10.1136/annrheumdis-2020-218281
  • Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350. doi:10.1136/rmdopen-2020-001350
  • Saricaoglu EM, Hasanoglu I, Guner RJ. The first reactive arthritis case associated with COVID‐19. J Med Virol. 2021;93:192–193. doi:10.1002/jmv.26296
  • Ducatez N, Chancel M, Douadi Y, et al. Primary meningococcal arthritis in a COVID-19 18-year-old man: a case report and review of the literature. BMC Infect Dis. 2021;21:1–4. doi:10.1186/s12879-021-06211-7
  • Karaarslan F, Güneri FD, Kardeş SJ. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41:289–296. doi:10.1007/s10067-021-05942-x
  • Karaarslan F, Demircioğlu Güneri F, Kardeş SJ. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews. Rheumatol Int. 2021;41:1263–1271. doi:10.1007/s00296-021-04882-8
  • Tsai L, Hsieh S, Chang YJ. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14:113.
  • Leung TW, Wong KS, Hui AC, et al. Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. Arch Neurol. 2005;62:1113–1117. doi:10.1001/archneur.62.7.1113
  • Griffith JF. Musculoskeletal Complications of Severe Acute Respiratory Syndrome. Semin Musculoskelet Radiol. © Thieme Medical Publishers; 2011.
  • Bakılan F, Gökmen İG, Ortanca B, et al. Musculoskeletal symptoms and related factors in postacute COVID‐19 patients. Int J Clin Pract. 2021;75:e14734. doi:10.1111/ijcp.14734